New Developments in the Use of Biologics and Other Modalities in the Management of Lateral Epicondylitis

Cynthia A Kahlenberg, Michael Knesek, Michael A Terry, Cynthia A Kahlenberg, Michael Knesek, Michael A Terry

Abstract

Lateral epicondylitis is a common source of elbow pain. Though it is often a self-limited condition, refractory lateral epicondylitis can lead to problems with activities of daily living and sometimes requires sick leave from work. Therefore prompt treatment is essential. Histopathologic studies have suggested that lateral epicondylitis is a tendinopathy, associated with apoptosis and autophagy, rather than a tendonitis associated with inflammation. Although corticosteroids have been used for short-term treatment, recent studies have suggested that they are not helpful and may even be harmful and delay healing in the treatment of lateral epicondylitis. Researchers have recently begun to investigate the use of biologics as potential treatment options for lateral epicondylitis. Autologous blood preparations including platelet rich plasma (PRP) and autologous whole blood injections (ABIs) have been proposed in order to deliver growth factors and other nutrients to the diseased tendon. Stem cell therapies have also been suggested as a method of improving tendon healing. This review discusses the current evidence for the use of PRP, ABI, and stem cell therapies for treatment of lateral epicondylitis. We also review the evidence for nonbiologic treatments including corticosteroids, prolotherapy, botulinum toxin A, and nitric oxide.

References

    1. Verhaar J. A. N. Tennis elbow. Anatomical, epidemiological and therapeutic aspects. International Orthopaedics. 1994;18(5):263–267.
    1. Shiri R., Viikari-Juntura E., Varonen H., Heliövaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. The American Journal of Epidemiology. 2006;164(11):1065–1074. doi: 10.1093/aje/kwj325.
    1. Kaux J.-F., Forthomme B., le Goff C., Crielaard J.-M., Croisier J.-L. Current opinions on tendinopathy. Journal of Sports Science and Medicine. 2011;10(2):238–253.
    1. Kraushaar B. S., Nirschl R. P. Tendinosis of the elbow (Tennis elbow): clinical features and findings of histological, immunohistochemical, and electron microscopy studies. The Journal of Bone & Joint Surgery—American Volume. 1999;81(2):259–278. doi: 10.1302/0301-620x.81b2.9154.
    1. Cyriax J. The pathology and treatment of tennis elbow. The Journal of Bone and Joint Surgery. American Volume. 1936;18:921–940.
    1. Calfee R. P., Patel A., DaSilva M. F., Akelman E. Management of lateral epicondylitis: current concepts. Journal of the American Academy of Orthopaedic Surgeons. 2008;16(1):19–29.
    1. Ahmad Z., Siddiqui N., Malik S. S., Abdus-Samee M., Tytherleigh-Strong G., Rushton N. Lateral epicondylitis: a review of pathology and management. The Bone & Joint Journal. 2013;95(9):1158–1164.
    1. Hay E. M., Paterson S. M., Lewis M., Hosie G., Croft P. Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care. British Medical Journal. 1999;319(7215):964–968. doi: 10.1136/bmj.319.7215.964.
    1. Taylor S. A., Hannafin J. A. Evaluation and management of elbow tendinopathy. Sports Health. 2012;4(5):384–393. doi: 10.1177/1941738112454651.
    1. Walker-Bone K., Palmer K. T., Reading I., Coggon D., Cooper C. Occupation and epicondylitis: a population-based study. Rheumatology. 2012;51(2):305–310. doi: 10.1093/rheumatology/ker228.ker228
    1. Chen J., Wang A., Xu J., Zheng M. In chronic lateral epicondylitis, apoptosis and autophagic cell death occur in the extensor carpi radialis brevis tendon. Journal of Shoulder and Elbow Surgery. 2010;19(3):355–362. doi: 10.1016/j.jse.2009.07.064.
    1. Alfredson H., Ljung B.-O., Thorsen K., Lorentzon R. In vivo investigation of ECRB tendons with microdialysis technique—no signs of inflammation but high amounts of glutamate in tennis elbow. Acta Orthopaedica Scandinavica. 2000;71(5):475–479. doi: 10.1080/000164700317381162.
    1. Nirschl R. P. Prevention and treatment of elbow and shoulder injuries in the tennis player. Clinics in Sports Medicine. 1988;7(2):289–308.
    1. Nirschl R. P., Pettrone F. A. Tennis elbow. The surgical treatment of lateral epicondylitis. Journal of Bone and Joint Surgery—Series A. 1979;61(6):832–839.
    1. Tuoheti Y., Itoi E., Pradhan R. L., et al. Apoptosis in the supraspinatus tendon with stage II subacromial impingement. Journal of Shoulder and Elbow Surgery. 2005;14(5):535–541. doi: 10.1016/j.jse.2005.01.001.
    1. Wu B., Chen J., Rosa T. D., et al. Cellular response and extracellular matrix breakdown in rotator cuff tendon rupture. Archives of Orthopaedic and Trauma Surgery. 2011;131(3):405–411. doi: 10.1007/s00402-010-1157-5.
    1. Yuan J., Murrell G. A. C., Wei A.-Q., Wang M.-X. Apoptosis in rotator cuff tendonopathy. Journal of Orthopaedic Research. 2002;20(6):1372–1379. doi: 10.1016/S0736-0266(02)00075-X.
    1. Wang A., Breidahl W., Mackie K. E., et al. Autologous tenocyte injection for the treatment of severe, chronic resistant lateral epicondylitis: a pilot study. The American Journal of Sports Medicine. 2013;41(12):2925–2932. doi: 10.1177/0363546513504285.
    1. Othman A. M. A. Arthroscopic versus percutaneous release of common extensor origin for treatment of chronic tennis elbow. Archives of Orthopaedic and Trauma Surgery. 2011;131(3):383–388. doi: 10.1007/s00402-011-1260-2.
    1. Croisier J.-L., Foidart-Dessalle M., Tinant F., Crielaard J.-M., Forthomme B. An isokinetic eccentric programme for the management of chronic lateral epicondylar tendinopathy. British Journal of Sports Medicine. 2007;41(4):269–275. doi: 10.1136/bjsm.2006.033324.
    1. Smidt N., van der Windt D. A. W. M., Assendelft W. J. J., Devillé W. L. J. M., Korthals-de Bos I. B. C., Bouter L. M. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: A randomised controlled trial. The Lancet. 2002;359(9307):657–662. doi: 10.1016/s0140-6736(02)07811-x.
    1. Bisset L., Smidt N., van der Windt D. A., et al. Conservative treatments for tennis elbow—do subgroups of patients respond differently? Rheumatology. 2007;46(10):1601–1605. doi: 10.1093/rheumatology/kem192.
    1. Hall M. P., Band P. A., Meislin R. T., Jazrawi L. M., Cardone D. A. Platelet-rich plasma: current concepts and application in sports medicine. Journal of the American Academy of Orthopaedic Surgeons. 2009;17(10):602–608.
    1. Ahmad Z., Howard D., Brooks R. A., et al. The role of platelet rich plasma in musculoskeletal science. JRSM Short Reports. 2012;3(6):p. 40. doi: 10.1258/shorts.2011.011148.
    1. de Mos M., van der Windt A. E., Jahr H., et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. American Journal of Sports Medicine. 2008;36(6):1171–1178. doi: 10.1177/0363546508314430.
    1. Edwards S. G., Calandruccio J. H. Autologous blood injections for refractory lateral epicondylitis. The Journal of Hand Surgery. 2003;28(2):272–278. doi: 10.1053/jhsu.2003.50041.
    1. Creaney L., Wallace A., Curtis M., Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. British Journal of Sports Medicine. 2011;45(12):966–971. doi: 10.1136/bjsm.2010.082503.
    1. Wolf J. M., Ozer K., Scott F., Gordon M. J. V., Williams A. E. Comparison of autologous blood, corticosteroid, and saline injection in the treatment of lateral epicondylitis: a prospective, randomized, controlled multicenter study. The Journal of Hand Surgery. 2011;36(8):1269–1272. doi: 10.1016/j.jhsa.2011.05.014.
    1. Hsu W. K., Mishra A., Rodeo S. R., et al. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. The Journal of the American Academy of Orthopaedic Surgeons. 2013;21(12):739–748. doi: 10.5435/jaaos-21-12-739.
    1. Kaux J.-F., Crielaard J.-M. Platelet-rich plasma application in the management of chronic tendinopathies. Acta Orthopaedica Belgica. 2013;79(1):10–15.
    1. Engebretsen L., Steffen K., Alsousou J., et al. IOC consensus paper on the use of platelet-rich plasma in sports medicine. British Journal of Sports Medicine. 2010;44(15):1072–1081. doi: 10.1136/bjsm.2010.079822.
    1. Marx R. E. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant dentistry. 2001;10(4):225–228. doi: 10.1097/00008505-200110000-00002.
    1. Pietrzak W. S., Eppley B. L. Platelet rich plasma: biology and new technology. The Journal of Craniofacial Surgery. 2005;16(6):1043–1054. doi: 10.1097/.
    1. Anitua E., Andía I., Sanchez M., et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. Journal of Orthopaedic Research. 2005;23(2):281–286. doi: 10.1016/j.orthres.2004.08.015.
    1. Kaux J.-F., Janssen L., Drion P., et al. Vascular endothelial growth factor-111 (VEGF-111) and tendon healing: preliminary results in a rat model of tendon injury. Muscles, Ligaments and Tendons Journal. 2014;4(1):24–28.
    1. Molloy T., Wang Y., Murrell G. A. C. The roles of growth factors in tendon and ligament healing. Sports Medicine. 2003;33(5):381–394. doi: 10.2165/00007256-200333050-00004.
    1. Zhang J., Wang J. H.-C. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. American Journal of Sports Medicine. 2010;38(12):2477–2486. doi: 10.1177/0363546510376750.
    1. Harris S. E., Bonewald L. F., Harris M. A., et al. Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. Journal of Bone and Mineral Research. 1994;9(6):855–863.
    1. Kaux J.-F., Bouvard M., Lecut C., et al. Reflections about the optimisation of the treatment of tendinopathies with PRP. Muscle, Ligaments and Tendons Journal. 2015;5(1):1–4.
    1. Mishra A., Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. American Journal of Sports Medicine. 2006;34(11):1774–1778. doi: 10.1177/0363546506288850.
    1. Mishra A. K., Skrepnik N. V., Edwards S. G., et al. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. American Journal of Sports Medicine. 2014;42(2):463–471. doi: 10.1177/0363546513494359.
    1. Peerbooms J. C., Sluimer J., Bruijn D. J., Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. American Journal of Sports Medicine. 2010;38(2):255–262. doi: 10.1177/0363546509355445.
    1. Gosens T., Peerbooms J. C., van Laar W., den Oudsten B. L. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. American Journal of Sports Medicine. 2011;39(6):1200–1208. doi: 10.1177/0363546510397173.
    1. Krogh T. P., Fredberg U., Stengaard-Pedersen K., Christensen R., Jensen P., Ellingsen T. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. The American Journal of Sports Medicine. 2013;41(3):625–635. doi: 10.1177/0363546512472975.
    1. Thanasas C., Papadimitriou G., Charalambidis C., Paraskevopoulos I., Papanikolaou A. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. The American Journal of Sports Medicine. 2011;39(10):2130–2134. doi: 10.1177/0363546511417113.
    1. Raeissadat S. A., Rayegani S. M., Hassanabadi H., Rahimi R., Sedighipour L., Rostami K. Is Platelet-rich plasma superior to whole blood in the management of chronic tennis elbow: one year randomized clinical trial. BMC Sports Science, Medicine and Rehabilitation. 2014;6, article 12 doi: 10.1186/2052-1847-6-12.
    1. Kaux J.-F., Croisier J.-L., Léonard P., le Goff C., Crielaard J.-M. Exuberant inflammatory reaction as a side effect of platelet-rich plasma injection in treating one case of tendinopathy. Clinical Journal of Sport Medicine. 2014;24(2):150–152. doi: 10.1097/jsm.0b013e31829aa410.
    1. Chen J., Yu Q., Wu B., et al. Autologous tenocyte therapy for experimental achilles tendinopathy in a rabbit model. Tissue Engineering—Part A. 2011;17(15-16):2037–2048. doi: 10.1089/ten.tea.2010.0492.
    1. Chen J. M., Willers C., Xu J., Wang A., Zheng M.-H. Autologous tenocyte therapy using porcine-derived bioscaffolds for massive rotator cuff defect in rabbits. Tissue Engineering. 2007;13(7):1479–1491. doi: 10.1089/ten.2006.0266.
    1. Harris M. T., Butler D. L., Boivin G. P., Florer J. B., Schantz E. J., Wenstrup R. J. Mesenchymal stem cells used for rabbit tendon repair can form ectopic bone and express alkaline phosphatase activity in constructs. Journal of Orthopaedic Research. 2004;22(5):998–1003. doi: 10.1016/j.orthres.2004.02.012.
    1. Connell D., Datir A., Alyas F., Curtis M. Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. British Journal of Sports Medicine. 2009;43(4):293–298. doi: 10.1136/bjsm.2008.056457.
    1. Singh A., Gangwar D., Singh S. Bone marrow injection: a novel treatment for tennis elbow. Journal of Natural Science, Biology and Medicine. 2014;5(2):389–391. doi: 10.4103/0976-9668.136198.
    1. Pascual-Garrido C., Rolón A., Makino A. Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup. Stem Cells International. 2012;2012:5. doi: 10.1155/2012/953510.953510
    1. Morré H. H. E., Keizer S. B., Os J. J. V. Treatment of chronic tennis elbow with botulinum toxin. The Lancet. 1997;349(9067):p. 1746. doi: 10.1016/s0140-6736(05)62958-3.
    1. Wong S. M., Hui A. C. F., Tong P. Y., Poon D. W. F., Yu E., Wong L. K. S. Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine. 2005;143(11):793–797.
    1. Placzek R., Drescher W., Deuretzbacher G., Hempfing A., Meiss A. L. Treatment of chronic radial epicondylitis with botulinum toxin A. A double-blind, placebo-controlled, randomized multicenter study. The Journal of Bone and Joint Surgery—American Volume. 2007;89(2):255–260. doi: 10.2106/jbjs.f.00401.
    1. Lin Y.-C., Tu Y.-K., Chen S.-S., Lin I.-L., Chen S.-C., Guo H.-R. Comparison between botulinum toxin and corticosteroid injection in the treatment of acute and subacute tennis elbow: a prospective, randomized, double-blind, active drug-controlled pilot study. American Journal of Physical Medicine & Rehabilitation. 2010;89(8):653–659. doi: 10.1097/phm.0b013e3181cf564d.
    1. Ljung B.-O., Alfredson H., Forsgren S. Neurokinin 1-receptors and sensory neuropeptides in tendon insertions at the medial and lateral epicondyles of the humerus. Studies on tennis elbow and medial epicondylalgia. Journal of Orthopaedic Research. 2004;22(2):321–327. doi: 10.1016/S0736-0266(03)00183-9.
    1. Callebaut I., Vandewalle E., Hox V., et al. Nasal corticosteroid treatment reduces substance P levels in tear fluid in allergic rhinoconjunctivitis. Annals of Allergy, Asthma & Immunology. 2012;109(2):141–146. doi: 10.1016/j.anai.2012.06.008.
    1. Bisset L., Beller E., Jull G., Brooks P., Darnell R., Vicenzino B. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. British Medical Journal. 2006;333(7575):939–941. doi: 10.1136/.
    1. Smith A. G., Kosygan K., Williams H., Newman R. J. Common extensor tendon rupture following corticosteroid injection for lateral tendinosis of the elbow. British Journal of Sports Medicine. 1999;33(6):423–425. doi: 10.1136/bjsm.33.6.423.
    1. Rabago D., Slattengren A., Zgierska A. Prolotherapy in primary care practice. Primary Care—Clinics in Office Practice. 2010;37(1):65–80. doi: 10.1016/j.pop.2009.09.013.
    1. Rabago D., Best T. M., Zgierska A. E., Zeisig E., Ryan M., Crane D. A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma. British Journal of Sports Medicine. 2009;43(7):471–481. doi: 10.1136/bjsm.2008.052761.
    1. Scarpone M., Rabago D. P., Zgierska A., Arbogast G., Snell E. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clinical Journal of Sport Medicine. 2008;18(3):248–254. doi: 10.1097/jsm.0b013e318170fc87.
    1. Carpenter J. E., Flanagan C. L., Thomopoulos S., Yian E. H., Soslowsky L. J. The effects of overuse combined with intrinsic or extrinsic alterations in an animal model of rotator cuff tendinosis. American Journal of Sports Medicine. 1998;26(6):801–807.
    1. Xia W., Szomor Z., Wang Y., Murrell G. A. C. Nitric oxide enhances collagen synthesis in cultured human tendon cells. Journal of Orthopaedic Research. 2006;24(2):159–172. doi: 10.1002/jor.20060.
    1. McCallum S. D. A., Paoloni J. A., Murrell G. A. C. Five-year prospective comparison study of topical glyceryl trinitrate treatment of chronic lateral epicondylosis at the elbow. British Journal of Sports Medicine. 2011;45(5):416–420. doi: 10.1136/bjsm.2009.061002.
    1. Paoloni J. A., Appleyard R. C., Nelson J., Murrell G. A. C. Topical nitric oxide application in the treatment of chronic extensor tendinosis at the elbow: a randomized, double-blinded, placebo-controlled clinical trial. The American Journal of Sports Medicine. 2003;31(6):915–920.
    1. Paoloni J. A., Murrell G. A. C., Burch R. M., Ang R. Y. Randomised, double-blind, placebo-controlled clinical trial of a new topical glyceryl trinitrate patch for chronic lateral epicondylosis. British Journal of Sports Medicine. 2009;43(4):299–302. doi: 10.1136/bjsm.2008.053108.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться